Since its establishment in 2010, Lapam Capital has been dedicated to investing in biotechnology and medical sectors. As a venture capital firm, its primary focus is to provide funding for early-stage healthcare startups. Lapam Capital's investment strategy is centered on identifying innovative technologies and business models that have the potential to disrupt the healthcare industry. The firm's experienced team of investors and advisors work closely with portfolio companies to provide strategic guidance and support, helping them to achieve their growth objectives. With a strong presence in China's healthcare market, Lapam Capital is well-positioned to capitalize on the country's rapidly growing demand for innovative healthcare solutions.